文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克中血管升压药启动时间与死亡率增加无关

Time to Vasopressor Initiation Is Not Associated With Increased Mortality in Patients With Septic Shock.
PubMed 文献 · Ann Emerg Med · 2025-11-04
一句话结论在这项大型回顾性队列中,从首次低血压到启动血管升压药的时间与90天死亡率或无血管升压药天数无关。

该研究为回顾性队列研究,基于OneFlorida Data Trust全州医疗数据,纳入2012至2018年间4,699例脓毒性休克患者,定义为住院期间至少1次低血压(收缩压≤100 mmHg)后接受血管升压药,且具有脓毒症ICD-9/10编码或感染编码并接受静脉抗生素。主要结局为90天死亡率,发生率为34%(n=1,610)。多因素logistic回归结合LASSO变量选择显示,血管升压药启动时间与90天死亡率无关(OR 1.01;95%CI 1.00至1.02),也与无血管升压药天数无关。独立预测因素包括年龄、机械通气、SOFA评分实验室组分、乳酸水平、慢性高血压和肝病。

要点

  • 在4,699例脓毒性休克患者中,从首次低血压到启动血管升压药的时间与90天死亡率无关(OR 1.01;95%CI 1.00至1.02)。
  • 90天死亡率为34%(n=1,610)。
  • 机械通气(OR 2.98;95%CI 2.56至3.48)、乳酸水平(OR 1.10;95%CI 1.08至1.13)和肝病(OR 1.54;95%CI 1.30至1.82)为独立预测因素。
  • 慢性高血压与90天死亡率呈负相关(OR 0.60;95%CI 0.52至0.70)。
  • 血管升压药启动时间不是无血管升压药天数的独立预测因素。

适用人群与场景

  • 脓毒性休克患者,纳入标准为住院期间至少1次低血压(收缩压≤100 mmHg)后接受血管升压药,且具有脓毒症ICD-9或ICD-10编码,或具有感染ICD编码并接受静脉抗生素。

诊断标准与关键阈值

  • 脓毒性休克定义:住院期间至少1次低血压(收缩压≤100 mmHg)后接受血管升压药,且具有脓毒症ICD-9/10编码或感染ICD编码并接受静脉抗生素。

研究设计与关键结果

  • 研究类型:回顾性队列研究,基于OneFlorida Data Trust全州医疗数据,纳入2012至2018年间4,699例脓毒性休克患者。
  • 主要结局:90天死亡率34%(n=1,610)。
  • 血管升压药启动时间与90天死亡率无关(OR 1.01;95%CI 1.00至1.02)。
  • 独立预测因素:年龄(OR 1.04;95%CI 1.04至1.05)、机械通气(OR 2.98;95%CI 2.56至3.48)、SOFA评分实验室组分(OR 1.18;95%CI 1.14至1.23)、乳酸水平(OR 1.10;95%CI 1.08至1.13)、慢性高血压(OR 0.60;95%CI 0.52至0.70)、肝病(OR 1.54;95%CI 1.30至1.82)。
  • 血管升压药启动时间不是无血管升压药天数的独立预测因素。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在这项大型脓毒性休克队列中,从首次低血压到启动血管升压药的时间与90天死亡率或无血管升压药天数无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: The optimal timing of vasopressor initiation in septic shock remains unclear. Our objective was to evaluate the association between time to vasopressor initiation and mortality.

METHODS: This was a retrospective cohort study of patients with septic shock in the OneFlorida Data Trust, a statewide repository of health care data. We included patients if they received vasopressors during hospitalization after at least 1 episode of hypotension (systolic blood pressure ≤100 mmHg) and had either (1) an International Classification of Disease 9 or 10 code for sepsis, or (2) an International Classification of Disease code for infection and received IV antibiotics. The primary outcome was 90-day mortality. The secondary outcome was vasopressor-free days. We used multiple logistic regression with Least Absolute Shrinkage and Selection Operator for variable selection to assess associations with 90-day mortality.

RESULTS: There were 4,699 patients with septic shock between 2012 and 2018 included. The primary outcome, 90-day mortality, was present in 34% (n=1,610). Time to vasopressor initiation was not found to be associated with 90-day mortality (odds ratio [OR] 1.01; 95% confidence interval [CI] 1.00 to 1.02). Independent predictors included age (OR 1.04; 95% CI 1.04 to 1.05), mechanical ventilation (OR 2.98; 95% CI 2.56 to 3.48), laboratory components of the Sequential Organ Failure Assessment score (OR 1.18; 95% CI 1.14 to 1.23), lactate level (OR 1.10; 95% CI 1.08 to 1.13), chronic hypertension (OR 0.60; 95% CI 0.52 to 0.70), and liver disease (OR 1.54; 95% CI 1.30 to 1.82). Time to vasopressor initiation was not found to be an independent predictor of vasopressor-free days.

CONCLUSION: Time from first hypotensive episode to vasopressor initiation was not found to be associated with 90-day mortality or vasopressor-free days in this large cohort of septic shock patients.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Black LP, Hopson C, Puskarich MA, et al. Time to Vasopressor Initiation Is Not Associated With Increased Mortality in Patients With Septic Shock. Ann Emerg Med. 2025. PMID: 41186550. doi:10.1016/j.annemergmed.2025.09.024

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。